Luminex Beats Street Expectations (LMNX)

Luminex Corporation (NASDAQ: LMNX) released a 8-K filing in which the company tightened and lowered its 2009 full year guidance from $118mn-$126mn to $119mn-$121mn. This implies a 4Q revenue guidance of $ 36.5mn to $38.5mn above consensus estimates of $34.7 million.

Analysts at Thomas Weisel Partners remain Marketweight on the stock and have revised their 12 month target price to $16.00.

It seems to me that since Luminex is expected to increase its ROE from 1.9% to 3.6% over a two year period, more adventurous investors may consider picking this stock. But I would go for a medium term perspective if I were you.